history of glp-1 drugs Reflections on the discovery as a satiety hormone: Implications for obesity therapy and future directions GLP-1 receptor agonists | How
Description
In order to qualify, adults must have heart disease and either overweight or obesity

Strong J, Driscoll MS

Available from: Deanfield J, Verma S, Scirica BM, Kahn SE, Emerson SS, Ryan D et al (2024) Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

doi: 10.1053/j.gastro.2009.09.004 [DOI] [PubMed] [Google Scholar] 127
Sixth, we performed the main analysis in the full cohort without prior matching

Some GLP-1 and related medications are approved for chronic weight management in eligible adults without diabetes
